{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:15:43Z","timestamp":1790766943513,"version":"4.1.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015518","name":"University of Nizwa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015518","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.clim.2022.109177","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T21:17:26Z","timestamp":1667855846000},"page":"109177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities"],"prefix":"10.1016","volume":"245","author":[{"given":"Murad","family":"Alahdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyad","family":"Elkord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2022.109177_bb0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","article-title":"Molecular immune pathogenesis and diagnosis of COVID-19","volume":"10","author":"Li","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.clim.2022.109177_bb0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.clim.2022.109177_bb0015","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.clim.2022.109177_bb0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0025","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1038\/s41467-018-07036-w","article-title":"Dynamic control of proinflammatory cytokines Il-1\u03b2 and Tnf-\u03b1 by macrophages in zebrafish spinal cord regeneration","volume":"9","author":"Tsarouchas","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2022.109177_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.570698","article-title":"Tempering macrophage plasticity for controlling SARS-CoV-2 infection for managing COVID-19 disease","volume":"11","author":"Toor","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.clim.2022.109177_bb0035","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2022.109177_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.870283","article-title":"Inhibitory immune checkpoint receptors and ligands as prognostic biomarkers in COVID-19 patients","volume":"13","author":"Al-Mterin","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0045","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4049\/jimmunol.2100446","article-title":"The Quality of SARS-CoV-2\u2013specific t cell functions differs in patients with mild\/moderate versus severe disease, and T cells expressing coinhibitory receptors are highly activated","volume":"207","author":"Shahbaz","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0050","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/s41423-021-00750-4","article-title":"Activation or exhaustion of CD8+ T cells in patients with COVID-19","volume":"18","author":"Rha","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0055","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2022.109177_bb0060","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.33549\/physiolres.934757","article-title":"Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19","volume":"70","author":"Barnova","year":"2021","journal-title":"Physiol. Res."},{"key":"10.1016\/j.clim.2022.109177_bb0065","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1073\/pnas.1718217115","article-title":"Role of PD-1 during effector CD8 T cell differentiation","volume":"115","author":"Ahn","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2022.109177_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.10.028","article-title":"NKG2A blockade potentiates CD8 T cell immunity induced by cancer vaccines","volume":"175","author":"van Montfoort","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.clim.2022.109177_bb0075","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146701","article-title":"PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response","volume":"6","author":"Loretelli","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.clim.2022.109177_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2020.08.1810","article-title":"1746P impact of PD-1\/PD-L1 blockade therapy in COVID-19 infected cancer patients (pts) hospitalization: results of an Italian study in the province of Modena and Reggio Emilia during SARS-CoV-2 outbreak","volume":"31","author":"Damato","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.clim.2022.109177_bb0085","series-title":"Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China, Clinical infectious diseases : an official Publication of the Infectious Diseases Society of America","author":"Qin","year":"2020"},{"key":"10.1016\/j.clim.2022.109177_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212915","article-title":"Correction: inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio","volume":"14","author":"Curbelo","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2022.109177_bb0095","first-page":"16","article-title":"Review and prospect of pathological features of corona virus disease","volume":"36","author":"Wang","year":"2020","journal-title":"Fa yi xue za zhi"},{"key":"10.1016\/j.clim.2022.109177_bb0100","article-title":"Genetic variation of the human alpha-2-Heremans-Schmid glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2022.109177_bb0105","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1038\/s41467-020-17240-2","article-title":"Immunological and inflammatory profiles in mild and severe cases of COVID-19","volume":"11","author":"Song","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2022.109177_bb0110","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De Biasi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2022.109177_bb0115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.humimm.2021.09.004","article-title":"Exhausted NK cells and cytokine storms in COVID-19: whether NK cell therapy could be a therapeutic choice","volume":"83","author":"Ghasemzadeh","year":"2022","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fcimb.2020.00049","article-title":"Characterizing the dysfunctional NK cell: assessing the clinical relevance of exhaustion, anergy, and senescence","volume":"10","author":"Judge","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.clim.2022.109177_bb0125","series-title":"Down-Regulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in COVID-19 Patients, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","author":"Ouyang","year":"2020"},{"key":"10.1016\/j.clim.2022.109177_bb0130","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.2147\/JIR.S322831","article-title":"Immunomodulation as a potent COVID-19 pharmacotherapy: past, present and future","volume":"14","author":"Hertanto","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.clim.2022.109177_bb0135","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S2213-2600(20)30226-5","article-title":"Immunomodulation in COVID-19","volume":"8","author":"Ingraham","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.clim.2022.109177_bb0140","doi-asserted-by":"crossref","first-page":"8623","DOI":"10.1073\/pnas.0809818106","article-title":"High antigen levels are the cause of T cell exhaustion during chronic viral infection","volume":"106","author":"Mueller","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2022.109177_bb0145","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/eji.201242852","article-title":"T-cell exhaustion due to persistent antigen: quantity not quality?","volume":"42","author":"Zuniga","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0150","doi-asserted-by":"crossref","first-page":"20453","DOI":"10.1073\/pnas.1008437107","article-title":"Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery","volume":"107","author":"Han","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2022.109177_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/v11100961","article-title":"Viral innate immune evasion and the pathogenesis of emerging RNA virus infections","volume":"11","author":"Nelemans","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.clim.2022.109177_bb0160","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-med-051215-031152","article-title":"Middle east respiratory syndrome: emergence of a pathogenic human coronavirus","volume":"68","author":"Fehr","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.clim.2022.109177_bb0165","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00281-016-0558-0","article-title":"The host immune response in respiratory virus infection: balancing virus clearance and immunopathology","volume":"38","author":"Newton","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.clim.2022.109177_bb0170","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12026-014-8534-z","article-title":"T cell-mediated immune response to respiratory coronaviruses","volume":"59","author":"Channappanavar","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.clim.2022.109177_bb0175","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrrheum.2009.136","article-title":"Sensors of the innate immune system: their mode of action","volume":"5","author":"Baccala","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2022.109177_bb0180","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood-2006-05-023770","article-title":"Control of coronavirus infection through plasmacytoid dendritic-cell\u2013derived type I interferon","volume":"109","author":"Cervantes-Barragan","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clim.2022.109177_bb0185","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4161\/auto.18935","article-title":"A novel method for autophagy detection in primary cells: impaired levels of macroautophagy in immunosenescent T cells","volume":"8","author":"Phadwal","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.clim.2022.109177_bb0190","series-title":"The Landscape of Lung Bronchoalveolar Immune Cells in COVID-19 Revealed by Single-Cell RNA Sequencing, medRxiv","author":"Liao","year":"2020"},{"key":"10.1016\/j.clim.2022.109177_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009878","article-title":"Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection","volume":"17","author":"Severa","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clim.2022.109177_bb0200","series-title":"Severe COVID-19 Patients Have Impaired Plasmacytoid Dendritic Cell-Mediated Control of SARS-CoV-2-Infected Cells, medRxiv","author":"Venet","year":"2021"},{"key":"10.1016\/j.clim.2022.109177_bb0205","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022111208","article-title":"Toll-like receptors matter: plasmacytoid dendritic cells in COVID-19","volume":"41","author":"Becker","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.clim.2022.109177_bb0210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41556-021-00685-y","article-title":"Monocyte and dendritic cell defects in COVID-19","volume":"23","author":"Wack","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.clim.2022.109177_bb0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41421-020-0168-9","article-title":"Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing","volume":"6","author":"Wen","year":"2020","journal-title":"Cell Disc."},{"key":"10.1016\/j.clim.2022.109177_bb0220","series-title":"The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes, medRxiv","author":"Chen","year":"2020"},{"key":"10.1016\/j.clim.2022.109177_bb0225","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fimmu.2013.00107","article-title":"When aging reaches CD4+ T-cells: phenotypic and functional changes","volume":"4","author":"Moro-Garcia","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0230","doi-asserted-by":"crossref","first-page":"S384","DOI":"10.21037\/tcr.2017.03.02","article-title":"Unlocking the epigenetic code of T cell exhaustion","volume":"6","author":"Wu","year":"2017","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.clim.2022.109177_bb0235","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.14336\/AD.2021.0709","article-title":"Regulatory T cells in COVID-19","volume":"12","author":"Wang","year":"2021","journal-title":"Aging Dis."},{"key":"10.1016\/j.clim.2022.109177_bb0240","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.humimm.2020.08.006","article-title":"Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China","volume":"81","author":"Chen","year":"2020","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0245","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41423-020-0447-2","article-title":"High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients","volume":"17","author":"Wang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0250","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/all.14647","article-title":"Immunological imprint of COVID-19 on human peripheral blood leukocyte populations","volume":"76","author":"Kratzer","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.clim.2022.109177_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.10.001","article-title":"Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ T cells in COVID-19","volume":"183","author":"Meckiff","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.clim.2022.109177_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.589380","article-title":"T-cell hyperactivation and paralysis in severe COVID-19 infection revealed by single-cell analysis","volume":"11","author":"Kalfaoglu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0265","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111315118","article-title":"Profound Treg perturbations correlate with COVID-19 severity","volume":"118","author":"Galv\u00e1n-Pe\u00f1a","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2022.109177_bb0270","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4049\/jimmunol.1202448","article-title":"The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection","volume":"190","author":"Cook","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0275","series-title":"NK Cells Negatively Regulate CD8 T Cells to Promote Immune Exhaustion and Chronic <em>Toxoplasma gondii<\/em> Infection, bioRxiv","author":"Ivanova","year":"2019"},{"key":"10.1016\/j.clim.2022.109177_bb0280","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109777","article-title":"Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents","volume":"140","author":"Yaqinuddin","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.clim.2022.109177_bb0290","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/s41467-019-09212-y","article-title":"NKG2A is a NK cell exhaustion checkpoint for HCV persistence","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.clim.2022.109177_bb0295","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41423-020-0450-7","article-title":"NKG2A and COVID-19: another brick in the wall","volume":"17","author":"Antonioli","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0300","doi-asserted-by":"crossref","first-page":"21797","DOI":"10.18632\/oncotarget.5490","article-title":"NK cell exhaustion: bad news for chronic disease?","volume":"6","author":"Schafer","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.clim.2022.109177_bb0305","article-title":"The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-&#x399","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2022.109177_bb0310","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1038\/s41467-021-26910-8","article-title":"SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis","volume":"12","author":"Yoo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2022.109177_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103500","article-title":"SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients","volume":"70","author":"Chen","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clim.2022.109177_bb0320","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/7403","article-title":"Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo","volume":"5","author":"Fernandez","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2022.109177_bb0325","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1182\/blood-2004-10-4035","article-title":"NK-dependent DC maturation is mediated by TNF\u03b1 and IFN\u03b3 released upon engagement of the NKp30 triggering receptor","volume":"106","author":"Vitale","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2022.109177_bb0330","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1395126","article-title":"Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses","volume":"7","author":"Fotaki","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.clim.2022.109177_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00159","article-title":"Cross-talks between natural killer cells and distinct subsets of dendritic cells","volume":"5","author":"Ferlazzo","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0340","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2020.06.013","article-title":"Lymphopenia during the COVID-19 infection: what it shows and what can be learned","volume":"225","author":"Tavakolpour","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2022.109177_bb0345","article-title":"Reduction of lymphocyte count at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study","author":"Fei","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.clim.2022.109177_bb0350","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.2232","article-title":"Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF","volume":"16","author":"Quigley","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2022.109177_bb0355","doi-asserted-by":"crossref","first-page":"219","DOI":"10.6026\/97320630016219","article-title":"CoViD-19 immunopathology and immunotherapy","volume":"16","author":"Chiappelli","year":"2020","journal-title":"Bioinformation"},{"key":"10.1016\/j.clim.2022.109177_bb0360","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0365","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg. Microbes. Infect."},{"key":"10.1016\/j.clim.2022.109177_bb0370","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1084\/jem.20061462","article-title":"Resolution of a chronic viral infection after interleukin-10 receptor blockade","volume":"203","author":"Ejrnaes","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2022.109177_bb0375","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1038\/s41375-021-01217-1","article-title":"Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia","volume":"35","author":"Rivas","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.clim.2022.109177_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002331","article-title":"The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors","volume":"7","author":"Pfefferle","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clim.2022.109177_bb0385","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.clim.2022.109177_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2020.11.004","article-title":"Role, function and regulation of the thymocyte selection-associated high mobility group box protein in CD8+ T cell exhaustion","volume":"229","author":"Cheng","year":"2021","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2022.109177_bb0395","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1073\/pnas.1905675116","article-title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8<sup>+<\/sup> T cell exhaustion","volume":"116","author":"Seo","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2022.109177_bb0400","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40364-021-00275-y","article-title":"TOX as a potential target for immunotherapy in lymphocytic malignancies","volume":"9","author":"Liang","year":"2021","journal-title":"Biomark. Res."},{"key":"10.1016\/j.clim.2022.109177_bb0405","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1126\/science.aae0491","article-title":"The epigenetic landscape of T cell exhaustion","volume":"354","author":"Sen","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.clim.2022.109177_bb0410","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nmeth.2688","article-title":"Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position","volume":"10","author":"Buenrostro","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.clim.2022.109177_bb0415","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.immuni.2009.06.019","article-title":"A role for the transcriptional repressor blimp-1 in CD8+ T cell exhaustion during chronic viral infection","volume":"31","author":"Shin","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2022.109177_bb0420","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2014.10.013","article-title":"The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8+ T cells during chronic infection","volume":"41","author":"Staron","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2022.109177_bb0425","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.4049\/jimmunol.1502643","article-title":"Genetic and epigenetic regulation of PD-1 expression","volume":"196","author":"Bally","year":"2016","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.109177_bb0430","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eng.2020.03.006","article-title":"A promising anti-cytokine-storm targeted therapy for COVID-19: the artificial-liver blood-purification system","volume":"7","author":"Zhang","year":"2020","journal-title":"Engineering"},{"key":"10.1016\/j.clim.2022.109177_bb0435","doi-asserted-by":"crossref","first-page":"682871","DOI":"10.3389\/fimmu.2021.682871","article-title":"The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome","volume":"12","author":"Kosyreva","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0440","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/22221751.2021.1884503","article-title":"COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue, Emerg","volume":"10","author":"Yongzhi","year":"2021","journal-title":"Microbes Infect."},{"key":"10.1016\/j.clim.2022.109177_bb0445","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41577-020-0312-7","article-title":"COVID-19: risk for cytokine targeting in chronic inflammatory diseases?","volume":"20","author":"Schett","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2022.109177_bb0450","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/art.41285","article-title":"On the alert for cytokine storm: immunopathology in COVID-19","volume":"72","author":"Henderson","year":"2020","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2022.109177_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.664349","article-title":"Pulmonary edema in COVID-19 patients: mechanisms and treatment potential","volume":"12","author":"Cui","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.clim.2022.109177_bb0460","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0465","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.clim.2022.109177_bb0470","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.micinf.2005.06.007","article-title":"Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)","volume":"8","author":"Chen","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.clim.2022.109177_bb0475","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clim.2022.109177_bb0480","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1603435113","article-title":"p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1","volume":"113","author":"Ma-Lauer","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.clim.2022.109177_bb0485","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1111\/jdv.16442","article-title":"Anti-Interleukin-6 receptor therapy-induced cutaneous symptoms resembling purpura fulminans in a patient with seropositive rheumatoid arthritis","volume":"34","author":"Nagy","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4\u20135","key":"10.1016\/j.clim.2022.109177_bb0490","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.micinf.2020.04.005","article-title":"The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement","volume":"22","author":"Hotez","year":"2020","journal-title":"Microbes Infect."},{"key":"10.1016\/j.clim.2022.109177_bb0495","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1474-4422(20)30081-8","article-title":"Interleukin-6 receptor blockade for the treatment of NMOSD","volume":"19","author":"Levy","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2022.109177_bb0500","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2022.109177_bb0505","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3346\/jkms.2016.31.11.1717","article-title":"Clinical progression and cytokine profiles of middle east respiratory syndrome coronavirus infection","volume":"31","author":"Kim","year":"2016","journal-title":"J. Korean Med. Sci."},{"issue":"8","key":"10.1016\/j.clim.2022.109177_bb0510","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients","volume":"71","author":"Chen","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109177_bb0515","volume":"8","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.clim.2022.109177_bb0520","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s40249-020-00780-6","article-title":"Increased circulating level of interleukin-6 and CD8+ T cell exhaustion are associated with progression of COVID-19","volume":"9","author":"Yang","year":"2020","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.clim.2022.109177_bb0525","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V118.21.360.360","article-title":"Correlation of serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after hematopoietic stem cell transplantation","volume":"118","author":"Kato","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clim.2022.109177_bb0530","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.7150\/thno.60040","article-title":"Converged Rab37\/IL-6 trafficking and STAT3\/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment","volume":"11","author":"Kuo","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.clim.2022.109177_bb0535","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1172\/JCI126022","article-title":"IL-6\/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion","volume":"129","author":"Chan","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.clim.2022.109177_bb0540","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib","volume":"53","author":"Wu","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.clim.2022.109177_bb0545","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.clim.2022.109177_bb0550","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4049\/immunohorizons.1800006","article-title":"IL-22: there is a gap in our knowledge","volume":"2","author":"Zenewicz","year":"2018","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.clim.2022.109177_bb0555","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/JLB.4COVCRA0820-481RRR","article-title":"Neutrophils mediate Th17 promotion in COVID-19 patients","volume":"109","author":"Parackova","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2022.109177_bb0560","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3390\/cells10061550","article-title":"The role of Th17 response in COVID-19","volume":"10","author":"Martonik","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.clim.2022.109177_bb0565","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/jcp.30047","article-title":"Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls","volume":"236","author":"Sadeghi","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.clim.2022.109177_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119395","article-title":"Ruxolitinib attenuates experimental autoimmune encephalomyelitis (EAE) development as animal models of multiple sclerosis (MS)","volume":"276","author":"Hosseini","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.clim.2022.109177_bb0575","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/2040622317738910","article-title":"Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis","volume":"9","author":"Frieder","year":"2018","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.clim.2022.109177_bb0580","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.1038\/s41598-018-28238-8","article-title":"1-Methyl-D-tryptophan Reduces Tumor CD133(+) cells, Wnt\/\u03b2-catenin and NF-\u03ba\u03b2p65 while Enhances Lymphocytes NF-\u03ba\u03b22, STAT3, and STAT4 Pathways in Murine Pancreatic Adenocarcinoma","volume":"8","author":"Alahdal","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2022.109177_bb0585","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.4161\/hv.25876","article-title":"Dendritic cell based vaccines for HIV infection: the way ahead","volume":"9","author":"Garc\u00eda","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.clim.2022.109177_bb0590","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.intimp.2015.06.019","article-title":"Efficacy of HBV-pulsed DCs in combination with entecavir in patients with chronic hepatitis B infection","volume":"27","author":"Wei","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clim.2022.109177_bb0595","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4110\/in.2014.14.3.128","article-title":"Differential roles of lung dendritic cell subsets against respiratory virus infection","volume":"14","author":"Kim","year":"2014","journal-title":"Immune Netw."},{"key":"10.1016\/j.clim.2022.109177_bb0600","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.3_suppl.200","article-title":"A phase I study to evaluate the safety of multiantigen stimulated tumor specific cell therapy (MASCT-I) in subjects with advanced gastric cancer","volume":"39","author":"Bu","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clim.2022.109177_bb0605","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","article-title":"SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19","volume":"587","author":"Braun","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.clim.2022.109177_bb0610","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20040035","article-title":"Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen","volume":"200","author":"de Heer","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2022.109177_bb0615","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fimmu.2013.00059","article-title":"Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity","volume":"4","author":"Gu\u00e9ry","year":"2013","journal-title":"Front. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622002583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622002583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:12:10Z","timestamp":1761495130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661622002583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":123,"alternative-id":["S1521661622002583"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.109177","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.109177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109177"}}